Obesity and Type 1 diabetes

Robotic pancreas transplant offers hope

For patients with Type 1 diabetes who don’t respond well to insulin or have other serious medical complications caused by their disease, pancreas transplantation offers hope for a cure.

But obese candidates who need a pancreas transplant often are denied the procedure because of poor outcomes, including high rates of incision infections, which are linked to an increased risk for failure and loss of the implanted organ. But now, surgeons at the University of Illinois at Chicago (UI Health) have demonstrated that obese patients with Type 1 diabetes can safely receive a pancreas transplant when the surgery is performed robotically. Their findings are published in the journal Transplant International

“The incidence of obesity among diabetic patients has risen dramatically over the past decades,” said Dr. Mario Spaggiari, assistant professor of surgery in the UIC College of Medicine, and lead author of the paper. “We have shown that by using robotic surgical techniques, this population can be safely transplanted, meaning that those who would have previously been denied can have access to this procedure that can vastly improve quality of life.”

Photo
Left to right: Dr. Mario Spaggiari, Arlys Martinez, a patient who successfully underwent the procedure, and Dr. Enrico Benedetti.
Source: University of Illinois at Chicago

Patients with diabetes who receive a pancreas transplant often can stop taking insulin, but they must stay on an anti-rejection drug regimen. Pancreas transplantation to treat Type 1 diabetes is not a first-line treatment for the disease and is only performed in patients who don’t respond to insulin injections, and who have other severe complications that arise from their diabetes. The procedure currently is performed using open surgical techniques where a single, long incision is made. The longer the incision, the higher the risk for an infection in the healing incision, which can lead to failure of the implanted organ. Robotic pancreas transplantation can be performed using a small, 5-centimeter incision, where the new organ will be slipped into the body, and four, 1-centimeter incisions for the surgical robot’s arms.

Dr. Enrico Benedetti, professor and head of surgery at the UIC College of Medicine, and his colleagues pioneered the use of robotic surgery for kidney transplantation in obese patients who were routinely denied the procedure because of poor outcomes. Benedetti is a co-author on the paper. Spaggiari, Benedetti and their colleagues looked back at the records of pancreas transplant patients who had procedures that took place at UI Health over a four-year period ending in December 2018. Forty-nine patients received a pancreas transplant over that time. Seventy-seven percent of the patients had Type 1 diabetes, and 70% had end-stage renal disease requiring dialysis. The average age of the patients was 43 years old.

We think that robotic techniques can also be used to improve outcomes for normal weight patients who need pancreas transplants because of the reduced risk for incision infection, which is linked to a higher risk of losing the transplanted organ

Enrico Benedetti

Patients with body mass indices at or above 30 (indicative of obesity) underwent procedures using robotically assisted surgical techniques. Ten of the procedures were performed robotically, and 39 were performed using traditional, open surgical techniques. Eight of the 10 patients who underwent robotically assisted pancreas transplantation also received a kidney during the procedure. Of the 39 patients who received a pancreas using traditional surgical techniques, 37 received a kidney at the same time.

Compared with patients who underwent traditional open transplantation, those who underwent the robotically assisted procedure had less blood loss, and surgical complication rates were similar in both groups. The length of post-operative hospitalization was shorter for patients who underwent the robotic procedure. None of the patients who underwent robotic pancreas transplant developed any wound complications. “We think that robotic techniques can also be used to improve outcomes for normal weight patients who need pancreas transplants because of the reduced risk for incision infection, which is linked to a higher risk of losing the transplanted organ,” said Dr. Enrico Benedetti, a co-author on the paper.


Source: University of Illinois at Chicago

11.07.2019

Read all latest stories

Related articles

Photo

The 129th Congress of the German Society of Surgery

Meeting with EH editor Brigitte Dinkloh, Congress Secretary Professor Alexis Ulrich MD (left), Assistant Medical Director at the Clinic for General, Visceral and Transplant Surgery at the University…

Photo

Bioprinting breakthrough

3D printed mini pancreas to help fight diabetes

First you see it as a transparent shape on a computer screen – a small electronic replica of the human pancreas. Then just 30 seconds later the tissue is printed out on a bioprinter, blood vessels…

Photo

Insulin inhibitory receptor

New promising target for diabetes treatment

Researchers from Helmholtz Zentrum Muenchen, the Technical University of Munich and the German Center for Diabetes have discovered a novel and druggable insulin inhibitory receptor, named inceptor.…

Related products

Fujifilm Wako – Autokit Total Ketone Bodies Assay

Clinical Chemistry

Fujifilm Wako – Autokit Total Ketone Bodies Assay

FUJIFILM Wako Chemicals Europe GmbH
Analyticon Biotechnologies AG - Urilyzer 100 Pro

Urinalysis

Analyticon Biotechnologies AG - Urilyzer 100 Pro

Analyticon Biotechnologies AG
Greiner – VACUETTE FC Mix tube

Blood Glucose

Greiner – VACUETTE FC Mix tube

Greiner Bio-One
Intermedical – "New" Radius XP with flat panel

Surgical Flat Panel C-Arms

Intermedical – "New" Radius XP with flat panel

INTERMEDICAL SRL
Lifotronic - FA-160 Immunofluorescence Analyzer

Other

Lifotronic - FA-160 Immunofluorescence Analyzer

Lifotronic Technology Co., Ltd
Subscribe to Newsletter